DS
SANA icon

David Shaw’s Sana Biotechnology SANA Stock Holding History

David Shaw’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$140K Buy
40,090
+1,420
+4% +$4.58K ﹤0.01% 4592
2026
Q1 		$111K Sell
38,670
-22,230
-37% -$87.6K ﹤0.01% 4276
2025
Q4 		$248K Buy
+60,900
New +$273K ﹤0.01% 4243
2025
Q3 		– Sell
-20,792
Closed -$56.8K – 4875
2025
Q2 		$56.8K Sell
20,792
-31,170
-60% -$64.3K ﹤0.01% 4166
2025
Q1 		$87.3K Buy
+51,962
New +$145K ﹤0.01% 4033
2024
Q4 		– Sell
-47,347
Closed -$197K – 4813
2024
Q3 		$197K Buy
+47,347
New +$249K ﹤0.01% 4163
2024
Q1 		– Sell
-254,403
Closed -$1.04M – 4679
2023
Q4 		$1.04M Buy
254,403
+1,634
+0.6% +$6.02K ﹤0.01% 3112
2023
Q3 		$978K Sell
252,769
-35,385
-12% -$190K ﹤0.01% 3077
2023
Q2 		$1.72M Sell
288,154
-239,030
-45% -$1.38M ﹤0.01% 2725
2023
Q1 		$1.72M Sell
527,184
-99,013
-16% -$396K ﹤0.01% 2797
2022
Q4 		$2.47M Buy
626,197
+89,480
+17% +$438K ﹤0.01% 2759
2022
Q3 		$3.22M Buy
536,717
+51,922
+11% +$375K ﹤0.01% 2559
2022
Q2 		$3.12M Buy
484,795
+244,246
+102% +$1.56M ﹤0.01% 2670
2022
Q1 		$1.99M Sell
240,549
-47,552
-17% -$384K ﹤0.01% 3309
2021
Q4 		$4.46M Buy
288,101
+40,512
+16% +$781K ﹤0.01% 2506
2021
Q3 		$5.58M Buy
+247,589
New +$5.2M 0.01% 2011

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

David Shaw's SANA Position: Q2 2026 in Review

David Shaw increased its Sana Biotechnology (SANA) stake by 3.7% in Q2 2026, buying an estimated $4.58K and bringing the position to 40,090 shares worth $140K. The position accounts for ﹤0.01% of the portfolio, ranked #4592.

David Shaw first reported a position in SANA in Q3 2021 and has held it in 16 quarters since. The position peaked at $5.58M in Q3 2021. 208 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • David Shaw held 40,090 shares of Sana Biotechnology worth $140K as of Q2 2026.
  • David Shaw bought 1,420 Sana Biotechnology shares in Q2 2026, an estimated $4.58K.
  • Sana Biotechnology made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #4592 holding.
  • David Shaw first reported a position in Sana Biotechnology in Q3 2021 and has held it in 16 quarters since.
  • David Shaw's Sana Biotechnology position peaked at $5.58M in Q3 2021.
  • 208 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.